BRCAvantage™: An In-depth Discussion
Quest Diagnostics’ Frederic Waldman, MD, and Wendy Conlon, CGC, will present an in-depth look at BRCA1 and BRCA2 testing, describe the role of the genetic counselor in the management of patients and explain the details of the Quest Diagnostics BRCAvantage™ tests and how to interpret results.
At the conclusion of this program, participants will be able to:
- Recognize the clinical relevance of BRCA1 and BRCA2 testing including risks associated with mutations and risk reduction options
- Understand the details of the Quest Diagnostics BRCAvantage™ tests including technical assay design, specific tests and annotation and reporting
- Discuss other BRCA testing services including genetic counseling, preauthorization, and financial assistance services